UNSPSC 41131503: Automated blood cell diluting apparatus

In this classification, an automated blood cell diluting apparatus is a fully automated or semi-automated device used to make appropriate dilutions of a blood sample for further testing. US FDA regulates Automated blood cell diluting apparatus under 21 CFR 864.5240 and under FDA product code GKH.

UNSPSC 41131503 Automated blood cell diluting apparatus (Commodity) covers laboratory hematology analyzers and specialized blood testing equipment that state and local health departments and academic medical centers procure to support clinical diagnostics, quality assurance, and screening operations. Recent solicitations show state and local buyers acquiring hemoglobin testing systems with automated sample-loading capabilities, proficiency testing samples for quality control, and consumable supplies for ICP-MS blood analysis — equipment that performs or supports automated or semi-automated blood cell and hemoglobin analysis at the point of acquisition. The issuing bodies span state health departments (Texas Health and Human Services Commission and Department of State Health Services), university health systems (University of Wisconsin-Madison), and likely clinical laboratories embedded within state and local public health infrastructure. These are typically capital or significant recurring-supply procurements handled through formal competitive bidding tied to equipment replacement, quality assurance mandates, or laboratory accreditation requirements.

Activity clusters in Texas and Wisconsin, with Texas showing the highest recent posting volume through its centralized state procurement process. The Texas Health and Human Services Commission issued an IFB (HHS0017310) posted May 1, 2026 for one D-10 Hemoglobin Testing System Compact Analyzer with rack loader capable of automated 50-sample loading for the South Texas Lab in Harlingen, with a May 18, 2026 response deadline and historical spending guidance of $45,050 to $80,000. The same Texas agency issued an earlier IFB (HHS0017071) posted February 18, 2026 for PerkinElmer ICP-MS consumables and supplies used in pediatric blood lead screening, with a March 5, 2026 deadline and historical spend ranging $20,000 to $30,000. The University of Wisconsin-Madison posted an RFB (2026-UWMSN-01287-RFB) on April 3, 2026 for custom-made hematology and whole blood chemistry proficiency testing samples with a May 5, 2026 response deadline. None of these solicitations carried set-aside designations for disadvantaged enterprises, though HUB subcontracting was encouraged in the Texas procurements where noted.